T. Rowe Price Associates’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.9M | Buy |
1,473,075
+377,350
| +34% | +$15.9M | 0.01% | 678 |
|
|
2025
Q1 | $41.5M | Sell |
1,095,725
-112,797
| -9% | -$4.27M | 0.01% | 775 |
|
|
2024
Q4 | $93M | Buy |
1,208,522
+88,442
| +8% | +$6.81M | 0.01% | 575 |
|
|
2024
Q3 | $64.5M | Buy |
1,120,080
+181,501
| +19% | +$10.4M | 0.01% | 683 |
|
|
2024
Q2 | $38.8M | Buy |
938,579
+402,580
| +75% | +$16.7M | ﹤0.01% | 796 |
|
|
2024
Q1 | $32.7M | Buy |
+535,999
| New | +$32.7M | ﹤0.01% | 835 |
|
|
2023
Q2 | – | Sell |
-2,692
| Closed | -$33K | – | 2925 |
|
|
2023
Q1 | $33K | Sell |
2,692
-504
| -16% | -$6.18K | ﹤0.01% | 2823 |
|
|
2022
Q4 | $114K | Buy |
3,196
+822
| +35% | +$29.3K | ﹤0.01% | 2687 |
|
|
2022
Q3 | $81K | Sell |
2,374
-357
| -13% | -$12.2K | ﹤0.01% | 2768 |
|
|
2022
Q2 | $100K | Buy |
2,731
+896
| +49% | +$32.8K | ﹤0.01% | 2747 |
|
|
2022
Q1 | $281K | Buy |
1,835
+53
| +3% | +$8.12K | ﹤0.01% | 2566 |
|
|
2021
Q4 | $527K | Buy |
1,782
+398
| +29% | +$118K | ﹤0.01% | 2361 |
|
|
2021
Q3 | $384K | Buy |
+1,384
| New | +$384K | ﹤0.01% | 2480 |
|